Steven Cohen (Point72) trim Crinetics Pharmaceuticals, Inc.
Steven Cohen (Point72) trim $124.6M of disclosed value in Crinetics Pharmaceuticals, Inc..
Signal
Investor Move
Action
Trim
Capital
$124.6M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.